Zentalis Pharmaceuticals (ZNTL) Assets (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Assets of $253.1 million for Q1 2026, down 34.1% year-over-year from $384.0 million in Q1 2025, and down 12.42% quarter-over-quarter from $289.0 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Assets (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Assets history runs 8 years deep, the most recent figure standing at $253.1 million for Q1 2026.
- In Q1 2026, Assets fell 34.1% year-over-year to $253.1 million; the TTM figure through Mar 2026 stood at $253.1 million (down 34.1% YoY), while the FY2025 annual figure was $289.0 million, down 32.85% from the prior year.
- Assets for Q1 2026 stood at $253.1 million, down from $289.0 million in the prior quarter.
- The five-year high for Assets was $621.4 million in Q2 2023, with the low at $253.1 million in Q1 2026.
- The 5-year median for Assets is $489.3 million (2023), against an average of $460.3 million.
- The sharpest annual moves came in 2022 and 2026: Assets jumped 99.98% in 2022, then tumbled 34.1% in 2026.
- Zentalis Pharmaceuticals' Assets stood at $539.3 million in 2022, then grew by 2.3% to $551.7 million in 2023, then retreated by 22.0% to $430.3 million in 2024, then tumbled by 32.85% to $289.0 million in 2025, then retreated by 12.42% to $253.1 million in 2026.
- Business Quant data shows ZNTL's Assets at $253.1 million in Q1 2026, $289.0 million in Q4 2025, and $327.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | 215.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 215.33 Mn |
| Mar 31, 2026 | 253.07 Mn |
| Dec 31, 2025 | 288.97 Mn |
| Sep 30, 2025 | 327.25 Mn |
| Jun 30, 2025 | 351.71 Mn |
| Mar 31, 2025 | 384.02 Mn |
| Dec 31, 2024 | 430.34 Mn |
| Sep 30, 2024 | 450.66 Mn |
| Jun 30, 2024 | 491.68 Mn |
| Mar 31, 2024 | 557.48 Mn |
| Dec 31, 2023 | 551.69 Mn |
| Sep 30, 2023 | 585.72 Mn |
| Jun 30, 2023 | 621.44 Mn |
| Mar 31, 2023 | 489.34 Mn |
| Dec 31, 2022 | 539.31 Mn |
| Sep 30, 2022 | 529.19 Mn |
| Jun 30, 2022 | 567.86 Mn |
| Mar 31, 2022 | 405.68 Mn |
| Dec 31, 2021 | 454.51 Mn |
| Sep 30, 2021 | 435.08 Mn |